Houston, TX — January 7, 2026 — Leads & Copy — Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), a SmellTech platform company, has partnered with Trusval Technology to advance AI Nose upstream and accelerate scent data accumulation in advanced wafer fabs. The agreement, announced today, focuses on digitizing scent as a native data language for artificial intelligence.
Ainos and Trusval, a Taiwan-based engineering and technical services provider specializing in semiconductor manufacturing environments, will establish a distribution and deployment partnership within the defined scope of semiconductor front-end manufacturing applications. Trusval will serve as Ainos’ authorized sales agent and deployment partner for AI Nose in this application scope. The agreement contractually defines an initial minimum purchase commitment of 600 AI Nose units, intended to support real-world deployment across front-end wafer fabrication environments.
The partnership aligns with Ainos’ long-term platform strategy to digitize smell and establish scent as a native AI data language. It reflects the Company’s 2026 execution focus on high-precision, high-reliability manufacturing environments. The agreement also complements Ainos’ existing collaborations within semiconductor back-end processes, extending SmellTech deployments upstream into front-end manufacturing stages where data consistency, process stability, and real-time sensing requirements are most stringent.
Chuchiao Kung, CEO of Trusval Technology, stated that AI Nose introduces a new sensing intelligence layer into existing wafer fab systems and looks forward to working closely with Ainos to deploy this capability in a structured and scalable manner across front-end manufacturing use cases.
Eddy Tsai, Chairman, President, and Chief Executive Officer of Ainos, commented that this partnership provides a strong and executable foundation for long-term SmellTech data accumulation and model evolution.
AI Nose digitizes scent into Smell ID, an AI-driven form of scent intelligence. The electronic nose platform integrates MEMS sensor arrays with proprietary AI algorithms designed to support ppb-level scent detection sensitivity, subject to application conditions and deployment configurations. Smell ID converts analog scent signals into structured, actionable data, while the proprietary Smell Language Model (SLM) is designed to learn, classify, and contextualize complex scent patterns over time.
Built upon accumulated scent data and medtech expertise, AI Nose is designed to support continuous monitoring, predictive analysis, and real-time alerts across industrial and manufacturing environments. AI Nose is offered under a SmellTech-as-a-Service architecture, intended to support ongoing access to scent intelligence, analytics, and AI-driven insights through subscription-based deployment models.
Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Ainos is redefining machine perception for the sensory age.
Investor Relations Contact:
Feifei Shen
Email: IR@ainos.com
Source: Ainos, Inc.
